News
ACOG: Routine Vitamin D Screening for Pregnant Women Not Necessary
- Author:
- Heidi Splete
Publish date: June 20, 2011
News
Many Health Care Providers Misuse HPV Tests
- Author:
- Heidi Splete
Publish date: June 20, 2011
Major Finding: Approximately 35% of hospital clinics and 32% of office-based providers reported performing low-risk HPV testing in women.Data...
News
Socioeconomic Factors Linked to Complications of Giant Cell Arteritis
- Author:
- Heidi Splete
Publish date: June 15, 2011
Video
Baghdad ER: Emergency Medicine in a War Zone
- Author:
- Heidi Splete
Publish date: June 14, 2011
News
AAD President Commends FDA on Sunscreen Regulations
- Author:
- Heidi Splete
Publish date: June 14, 2011
News
AAD President Commends FDA on Sunscreen Regulations
- Author:
- Heidi Splete
Publish date: June 14, 2011
News
AAD President Commends FDA on Sunscreen Regulations
- Author:
- Heidi Splete
Publish date: June 14, 2011
News
FDA's Sunscreen Regs Should Ease Skin Protection
- Author:
- Heidi Splete
Publish date: June 14, 2011
News
More Frequent HIV Testing May Protect Men Who Have Sex With Men
- Author:
- Heidi Splete
Publish date: June 2, 2011
News
More Frequent HIV Testing May Protect Men Who Have Sex With Men
- Author:
- Heidi Splete
Publish date: June 2, 2011
News
More Frequent HIV Testing May Protect Men Who Have Sex With Men
- Author:
- Heidi Splete
Publish date: June 2, 2011
News
High Carb Intake Raises Gallbladder Disease Risk
- Author:
- Heidi Splete
Publish date: June 1, 2011
News
High Carb Intake Raises Gallbladder Disease Risk for Pregnant Women
- Author:
- Heidi Splete
Publish date: May 24, 2011
Major Finding: Women in the highest quartile of starch consumption were 80% more likely than those in the lowest quartile to show signs of...
News
Telaprevir Improved Outcomes for Hep C Patients Who Failed Prior Therapy
- Author:
- Heidi Splete
Publish date: May 13, 2011
Major Finding: Among the prior relapsers, the response rate in the telaprevir patients was 83%-88%, compared with 23% in the placebo group.
News
Telaprevir Improved Outcomes for Hep C Patients Who Failed Prior Therapy
- Author:
- Heidi Splete
Publish date: May 13, 2011
Major Finding: Among the prior relapsers, the response rate in the telaprevir patients was 83%-88%, compared with 23% in the placebo group.